TORONTO, ONTARIO--(MARKET WIRE)--Aug 9, 2007 -- PharmEng International Inc. ("PharmEng") (CDNX:PII.V - News), a full-service consulting and contract manufacturing company, is pleased to announce that David G. Leonard is appointed the Keata Pharma President for the Sydney and Perth manufacturing sites. David will succeed Bernie Boudreau who will assume the new role as the Vice President of Corporate Development and Legal Affairs of PharmEng. Keata Pharma is a wholly owned subsidiary of ParmEng with manufacturing facilities in Perth, Ontario and new facilities in Sydney, Nova Scotia scheduled to open in the fourth quarter of this year.
